Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Spiration Announces Participation Of Several New Sites In IBV Valve Trial

Spiration, Inc. announced that several new clinical sites are actively recruiting patients for participation in a pivotal trial of the company’s minimally invasive treatment for severe emphysema. These sites include Akron General Medical Center in Akron, Ohio; Medical College of Wisconsin in Milwaukee, Wis.; National Jewish Health in Denver, Colo.; New York- Presbyterian Hospital/Columbia University Medical Center in New York, N.Y.; Southern Illinois University School of Medicine in Springfield, Ill.; University of Iowa Health Care in Iowa City, Iowa; University of California, San Diego Medical Center; the University of Chicago Medical Center; the University of Florida in Gainesville, Fla.; and the University of Washington Medical Center in Seattle, Wash.

“We’re very excited about the addition of these well-respected sites to the first-rate hospitals already participating in the IBV Valve Trial,” said Rick Shea, president and CEO, Spiration. “The approximately 30 sites actively enrolling patients in the study are leaders in their communities helping to advance medical research that may one day improve the lives of people with emphysema, a debilitating condition that severely impacts quality of life.”